4-hydroxycyclophosphamide has been researched along with ifosfamide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndt, CA; Balis, FM; Colvin, OM; McCully, CL; Poplack, DG | 1 |
| Borch, RF; Low, JE; Sladek, NE | 1 |
| Colvin, OM; Frenkel, E; Kamen, BA | 1 |
| Brueggemann, SK; Deeken, M; Klich, S; Peters, SO; Schlenke, P; Wagner, T | 1 |
4 other study(ies) available for 4-hydroxycyclophosphamide and ifosfamide
| Article | Year |
|---|---|
Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys.
Topics: Animals; Cyclophosphamide; Ifosfamide; Macaca mulatta; Male; Permeability | 1988 |
Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
Topics: Acrolein; Aldehydes; Buffers; Chemical Phenomena; Chemistry; Cyclophosphamide; Hydrogen-Ion Concentration; Ifosfamide; Kinetics; Nitrogen Mustard Compounds; Osmolar Concentration; Structure-Activity Relationship; Temperature | 1983 |
Ifosfamide: should the honeymoon be over?
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Child; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Drug Tolerance; Etoposide; Female; Humans; Ifosfamide; Kidney; Neuroblastoma; Time Factors | 1995 |
Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activity.
Topics: Acetaldehyde; Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Ifosfamide; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2002 |